Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹6,470 Cr
up ₹266 Cr vs Nov 2023
- Stocks held
- 32
- up 1 vs Nov 2023
- Top 10 weight
- 57.9%
- of the portfolio in its ten largest
- Cash & debt
- 1.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 7
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In December 2023 it disclosed 32 stocks worth ₹6,470 Cr, up ₹266 Cr from Nov 2023. Its largest positions were Sun Pharmaceutical Industries Limited (12.8%), Lupin Limited (7.8%), Cipla Limited (6.0%); the ten largest together made up 57.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.0% of its equity. Cash and debt stood at 1.5%. Compared with Nov 2023 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
79%
Top-10 weight is higher than 79% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
22%
Holds more cash than 22% of peers
Holdings in December 2023
Download CSVEvery line the fund disclosed, with the change against Nov 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.76%
- Δ weight
- down 0.19 pts
- Value
- ₹826 Cr
- Δ value
- up ₹22 Cr
- Status
- Added
- Weight
- 7.78%
- Δ weight
- down 0.08 pts
- Value
- ₹503 Cr
- Δ value
- up ₹16 Cr
- Status
- Added
- Weight
- 5.97%
- Δ weight
- down 0.09 pts
- Value
- ₹386 Cr
- Δ value
- up ₹10.5 Cr
- Status
- Added
- Weight
- 5.72%
- Δ weight
- down 0.06 pts
- Value
- ₹370 Cr
- Δ value
- up ₹11.4 Cr
- Status
- Added
- Weight
- 5.06%
- Δ weight
- up 0.19 pts
- Value
- ₹327 Cr
- Δ value
- up ₹25.5 Cr
- Status
- Added
- Weight
- 4.93%
- Δ weight
- down 0.20 pts
- Value
- ₹319 Cr
- Δ value
- up ₹54 L
- Status
- Held
- Weight
- 4.53%
- Δ weight
- down 0.05 pts
- Value
- ₹293 Cr
- Δ value
- up ₹8.6 Cr
- Status
- Added
- Weight
- 3.85%
- Δ weight
- down 0.34 pts
- Value
- ₹249 Cr
- Δ value
- down ₹11 Cr
- Status
- Trimmed
- Weight
- 3.73%
- Δ weight
- up 0.26 pts
- Value
- ₹242 Cr
- Δ value
- up ₹25.8 Cr
- Status
- Added
- Weight
- 3.57%
- Δ weight
- down 0.38 pts
- Value
- ₹231 Cr
- Δ value
- down ₹14.3 Cr
- Status
- Trimmed
- Weight
- 3.30%
- Δ weight
- up 0.05 pts
- Value
- ₹214 Cr
- Δ value
- up ₹11.7 Cr
- Status
- Added
- Weight
- 3.25%
- Δ weight
- down 0.40 pts
- Value
- ₹210 Cr
- Δ value
- down ₹16.4 Cr
- Status
- Trimmed
- Weight
- 3.20%
- Δ weight
- down 0.09 pts
- Value
- ₹207 Cr
- Δ value
- up ₹2.7 Cr
- Status
- Added
- Weight
- 3.12%
- Δ weight
- up 0.03 pts
- Value
- ₹202 Cr
- Δ value
- up ₹10.4 Cr
- Status
- Added
- Weight
- 3.03%
- Δ weight
- down 0.03 pts
- Value
- ₹196 Cr
- Δ value
- up ₹6.3 Cr
- Status
- Added
- Weight
- 3.01%
- Δ weight
- up 0.01 pts
- Value
- ₹194 Cr
- Δ value
- up ₹8.3 Cr
- Status
- Added
- Weight
- 2.94%
- Δ weight
- down 0.12 pts
- Value
- ₹190 Cr
- Δ value
- up ₹56 L
- Status
- Held
- Weight
- 2.70%
- Δ weight
- down 0.23 pts
- Value
- ₹175 Cr
- Δ value
- down ₹7.3 Cr
- Status
- Trimmed
- Weight
- 2.51%
- Δ weight
- up 0.22 pts
- Value
- ₹162 Cr
- Δ value
- up ₹20.6 Cr
- Status
- Added
- Weight
- 2.27%
- Δ weight
- up 0.09 pts
- Value
- ₹147 Cr
- Δ value
- up ₹11.6 Cr
- Status
- Added
- Weight
- 2.15%
- Δ weight
- up 0.08 pts
- Value
- ₹139 Cr
- Δ value
- up ₹10.8 Cr
- Status
- Added
- Weight
- 1.93%
- Δ weight
- up <0.01 pts
- Value
- ₹125 Cr
- Δ value
- up ₹5.4 Cr
- Status
- Added
- Weight
- 1.76%
- Δ weight
- up 0.16 pts
- Value
- ₹114 Cr
- Δ value
- up ₹14.8 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.46%
- Δ weight
- up 0.97 pts
- Value
- ₹94.6 Cr
- Δ value
- up ₹64.3 Cr
- Status
- Added
- Weight
- 1.14%
- Δ weight
- up 0.06 pts
- Value
- ₹73.8 Cr
- Δ value
- up ₹6.8 Cr
- Status
- Added
- Weight
- 1.12%
- Δ weight
- up 0.05 pts
- Value
- ₹72.5 Cr
- Δ value
- up ₹6 Cr
- Status
- Added
- Weight
- 0.94%
- Δ weight
- up 0.03 pts
- Value
- ₹61 Cr
- Δ value
- up ₹4.2 Cr
- Status
- Added
- Weight
- 0.76%
- Δ weight
- down 0.09 pts
- Value
- ₹49.2 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 0.54%
- Δ weight
- down 0.03 pts
- Value
- ₹35 Cr
- Δ value
- down ₹52 L
- Status
- Trimmed
- Weight
- 0.46%
- Δ weight
- up 0.08 pts
- Value
- ₹30 Cr
- Δ value
- up ₹6.4 Cr
- Status
- Added
- Weight
- 0.23%
- Δ weight
- down 0.01 pts
- Value
- ₹14.6 Cr
- Δ value
- down ₹17 L
- Status
- Trimmed
- Weight
- 0.18%
- Δ weight
- up 0.02 pts
- Value
- ₹11.7 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 0.10%
- Δ weight
- up 0.10 pts
- Value
- ₹6.4 Cr
- Δ value
- up ₹6.4 Cr
- Status
- New
What changed, Nov 2023 to Dec 2023
New New positions (1)
- AstraZeneca Pharma India Limited0.1% · ₹6.4 Cr
Exited Exited (0)
None.
Added Biggest additions
- JB Chemicals & Pharmaceuticals Limitedup ₹25.8 Cr (+0.26% pts)
- Gland Pharma Limitedup ₹25.5 Cr (+0.19% pts)
- Sun Pharmaceutical Industries Limitedup ₹22 Cr (−0.19% pts)
- GlaxoSmithKline Pharmaceuticals Limitedup ₹20.6 Cr (+0.22% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2023, the weight rose most in Pharmaceuticals & Biotechnology (+0.4 pts), and fell most in Retailing (−0.3 pts) and Healthcare Services (−0.1 pts).
- Pharmaceuticals & Biotechnology76.6% → 77.0%+0.4 pts
- Retailing4.0% → 3.6%−0.3 pts
- Healthcare Services18.2% → 18.1%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2020 | Dec 2022 | Jun 2023 | Sep 2023 | Nov 2023 | Dec 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.4% | 78.0% | 76.8% | 78.0% | 76.6% | 77.0% |
| Healthcare Services | 18.2% | 19.6% | 18.6% | 16.3% | 18.2% | 18.1% |
| Retailing | — | 0.4% | 3.1% | 4.3% | 4.0% | 3.6% |
| Pharmaceuticals | 2.4% | 1.6% | 1.2% | 1.1% | 1.1% | 1.1% |
| Healthcare Equipment & Supplies | — | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% |
Allocation in Dec 2023change vs Nov 2023
- Pharmaceuticals & Biotechnology (21)77.0%▲ 0.4 pts
- Healthcare Services (8)18.1%▼ 0.1 pts
- Retailing (1)3.6%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Dec 2023
1.5%
▲ 1.0 pts vs Nov 2023
- Cash alone
- 1.5%
- cash and net receivables
- A year earlier
- 0.4%
- Dec 2022 · now ▲ 1.0 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.